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Variable lymphocyte receptors (VLRs) are the adap-
tive immune receptors of jawless fish, which evolved
adaptive immunity independent of other vertebrates.
In lieu of the immunoglobulin fold-based T and B cell
receptors, lymphocyte-like cells of jawless fish
express VLRs (VLRA, VLRB, or VLRC) composed of
leucine-rich repeats and are similar to toll-like recep-
tors (TLRs) in structure, but antibodies (VLRB) and
T cell receptors (VLRA and VLRC) in function. Here,
we present the structural and biochemical character-
ization of VLR4, a VLRB, in complex with BclA, the
immunodominant glycoprotein of Bacillus anthracis
spores. Using a combination of crystallography,
mutagenesis, and binding studies, we delineate the
mode of antigen recognition and binding between
VLR4 and BclA, examine commonalities in VLRB
recognition of antigens, and demonstrate the poten-
tial of VLR4 as a diagnostic tool for the identification
of B. anthracis spores.
INTRODUCTION
All vertebrate animals have evolved an adaptive immune system
in order to generate a diverse repertoire of highly specific antic-
ipatory receptors against novel antigens (Cooper and Alder,
2006; Pancer et al., 2004). Fish of the phylum agnatha are the
most ancient lineage of vertebrates that persist today. These
jawless fish produce immune cells that are remarkably similar
in function to the B cells and T cells of other vertebrates.
However, these lymphocyte-like cells lack receptors carrying
the conventional immunoglobulin fold (Ig fold) of B and T cell
receptors (BCRs and TCRs, respectively). Instead, jawless fish
have independently evolved an adaptive immune system using
leucine-rich repeat (LRR) motifs as the protein scaffold rather
than the immunoglobulin domain (Pancer et al., 2004). LikeStructure 20,conventional immune receptors, these variable lymphocyte
receptors (VLRs) have both humoral (VLRB) and cell-mediated
functions (VLRA and VLRC), which are produced by discrete
populations of lymphocyte-like cells (Guo et al., 2009; Kasa-
matsu et al., 2010).
The germline lamprey VLR loci contain conserved regions for
the signal peptide, portions of the N- and C-terminal capping
domains, and the invariant stalk region. In lymphocyte-like cells,
LRRs are copied from cassettes that flank the incomplete germ-
line gene via a mechanism thought to resemble gene conversion
with putative roles for two cytidine deaminases that are ex-
pressed in specific populations of lymphocyte-like cells (Alder
et al., 2005; Rogozin et al., 2007). VLRA and VLRC are expressed
as membrane-bound receptors thought to resemble TCRs in
function (Deng et al., 2010; Guo et al., 2009; Kasamatsu et al.,
2010). VLRBs resemble BCRs and antibodies in that they can
be either membrane bound or secreted from VLRB+ cells. The
affinity of a single VLRB protomer for its antigen is usually in
the low micromolar range (Herrin et al., 2008; Velikovsky et al.,
2009). However, secreted VLRBs form large, disulfide-linked
octamers or decamers that show very high affinity for antigen
by using multivalency to increase avidity (Herrin et al., 2008).
VLR antigen-binding domains have a motif organization that
is highly similar to that of other LRR-containing proteins, such
as toll-like receptors (TLRs). The N-terminal capping region
(LRRNT) serves to stabilize the protein and covers what would
otherwise be the exposed end of the N-terminal hydrophobic
core of the LRR solenoid (Bella et al., 2008). The LRRNT is fol-
lowed by three or more LRR motifs: LRR1, LRRV, and LRRVe
and the connecting peptide (CP) that create the LRR solenoid
(Pancer et al., 2004). The C-terminal capping region (LRRCT)
acts to bury theC-terminal hydrophobic core of the LRR solenoid
using a long a helix (Bella et al., 2008). The LRRCT also contains
a highly variable insert (Rogozin et al., 2007), which forms an
extended loop that is crucial for contacting antigen. The b sheet
created by the LRRNT and LRR motifs, and CP forms a concave
surface, the variable residues of which, along with the LRRCT-
loop, compose the antigen-binding surface of VLRs (Deng
et al., 2010; Han et al., 2008; Velikovsky et al., 2009). In addition,
VLRs have an invariant C-terminal Thr/Pro stalk, a putative GPI479–486, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 479
Table 1. Data Collection and Refinement Statistics
VLR4-BclA-
Thr185Asn
3TWI
BclA-Pro159Ser
3TYJ
Data Collection
Wavelength (A˚) 1.033 1.000
Resolution (A˚) 50–2.55
(2.64–2.55)
40–2.15
(2.19–2.15)
Space group I222 P6322
Cell dimensions
a, b, c (A˚) 74.8, 146.5, 209.5 68.2, 68.2, 163.7
a, b, g (o) 90, 90, 90 90, 90, 120
No. of observations 116,551 144,923
Unique reflections 37,042 12,588
Redundancy 3.1 (2.9) 11.5 (7.8)
Completeness (%) 97.3 (99.1) 96.9 (97.9)
Rsym (%)
a 0.122 (0.581) 0.168 (0.647)
I/s 9.5 (2.0) 11.7 (3.2)
Refinement Statistics
Resolution 41.9–2.55
(2.61–2.55)
34–2.15
(2.21–2.15)
No. of reflections (working) 33,162 (2,559) 11,338 (840)
No. of reflections (test) 1,869 (131) 619 (40)
Rcryst (%)
b 0.19 (0.29) 0.21 (0.25)
Rfree (%)
c 0.23 (0.33) 0.23 (0.26)
No. of molecules/asu 3 1
No. of protein atoms 6,731 1,072
No. of protein chains 6 1
Overall B values (A˚2)
BclA 32.6 15.0
VLR4 (chains D, E, F) 38.6, 52.2, 98.0
Waters 39.1 32.8
Wilson B value (A˚2) 32.0 16.6
Ramachandran plot (%)d
Favored 96.4 100.0
Allowed 3.6 0.0
Disallowed 0.0 0.0
Rmsd
Bond length (A˚) 0.011 0.009
Angle (o) 1.21 1.22
Values in parentheses are for the outermost shell.
aRsym =
P
h
P
i jIi(h)hI(h)ij/
P
h
P
i Ii(h), where hIi(h)i is the average intensity
of i symmetry-related observations of reflections with Bragg index h.
bRcryst =
P
hkl jFobsFcalcj/
P
hkl Fobs.
cRfree is the same as Rcryst except for 5% of the data excluded from
refinement.
dRamachandran statistics were calculated with MolProbity.
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VLR4 Recognition of BclAattachment site, and aCys-rich region (Herrin et al., 2008; Pancer
et al., 2004), which is responsible for themultimerization of VLRB
into disulfide-linked oligomers and crucial for high-avidity VLRB.
In previous work, VLR4, a monoclonal VLRB specific for BclA,
was isolated from lampreys that had been immunized with puri-
fied exosporium from spores of Bacillus anthracis, the causative480 Structure 20, 479–486, March 7, 2012 ª2012 Elsevier Ltd All righagent of anthrax (Herrin et al., 2008). The exosporium is the
outermost layer of the B. anthracis spore, and BclA (the Bacillus
collagen-like protein of anthracis) makes up the hair-like nap
that is covalently attached to the exosporium basal layer (Tan
et al., 2011). BclA is expressed on spores of a limited number
of Bacillus species, all from the Bacillus cereus group. This
trimeric protein has a 38 amino acid N-terminal domain contain-
ing sequences required for basal layer attachment, a central
collagen-like domain, and a 134 residue C-terminal domain
(CTD) that drives trimerization (Boydston et al., 2005). The
collagen-like domain is polymorphic in length ranging from
51 to 228 amino acids (Sylvestre et al., 2003; Boydston et al.,
2005) and is heavily O-glycosylated (Daubenspeck et al.,
2004). Trimers of the CTD form the tips of the spore’s hair-like
nap and are the immunodominant target of vertebrate antibodies
(Steichen et al., 2003; Boydston et al., 2005; Swiecki et al., 2006).
B. anthracis is an uncommon human pathogen; however, infec-
tions from inhalation of bacterial spores have high mortality
unless promptly treated with antibiotics and intensive care
(Spencer, 2003). Unfortunately, B. anthracis spores have been
used as biological weapons and in the bioterrorism attacks of
2001 in the United States, highlighting the need for rapid diag-
nostics to identify B. anthracis spores from spores of highly
related but more benign species (Higgins et al., 2003). Here,
we describe the crystal structure and molecular interactions of
VLR4 with BclA and show VLR4 to be a unique reagent in its
ability to discriminate B. anthracis spores.
RESULTS
Engineering of BclA-CTD
In agreement with multiple studies, we found that the BclA-CTD
tended to form crystals in nearly every condition commonly used
for protein crystallization (Boydston et al., 2005; Liu et al., 2008;
Nuttall et al., 2011). To prevent crystallization of BclA-CTD alone
and facilitate formation of VLR4-BclA complex crystals, we intro-
duced a mutation in BclA-CTD to disrupt crystal packing based
on a previously determined BclA-CTD structure from our labora-
tory (Protein Data Bank [PDB] 2R6Q). We mutated Thr185, a key
residue in forming the BclA-CTD crystal lattice, to an Asnwith the
expectation that this conservative mutation would obstruct
BclA-CTD crystal growth without drastically altering the struc-
ture of BclA. The mutant BclA-CTD-Thr185Asn was expressed
and purified from E. coli and mixed with a monomeric VLR4 ex-
pressed from insect cells using a baculovirus expression system.
The VLR4 construct was C-terminally truncated to remove the
Thr/Pro stalk and Cys-rich regions that multimerize VLRB.
The strategy was highly successful and allowed crystals of the
VLR4-BclA complex to be grown in space group I222. X-ray
diffraction data were collected to 2.55 A˚ resolution (Table 1).
Comparison of the mutated BclA-CTD to wild-type structures
in the PDB indicated no major changes, including the loop con-
taining the mutated amino acid.
We also used biolayer interferometry to quantify VLR4 binding
to modified and wild-type BclA proteins. Binding of truncated
monomeric VLR4 containing the antigen-binding motifs (resi-
dues 22–188) to wild-type BclA-CTD resulted in a Kd of 2.6 mM
(Table 2), in agreement with relatively weak binding by mono-
meric VLRB (Herrin et al., 2008; Velikovsky et al., 2009). Thets reserved
Figure 1. The VLR4-BclA Structure
VLR4 binds BclA using its concave surface (green) and LRRCT-loop (pink). The
VLR4-binding site lies on the proximal end of BclA with respect to the spore,
near the termini.
(A) Stereo view of VLR4 interacting with a BclA monomer.
(B) Depiction of trimeric BclA decorated by VLR4.
Table 2. Binding of Monomeric VLR4 to Recombinant BclA-CTD
Variants
Sample Kd (M)
BclA-CTD-Ba 2.6 3 106
BclA-CTD-Thr185Asn 0.6 3 106
BclA-CTD-Ser129Ala 3.2 3 106
BclA-CTD-Glu130Gln 2.4 3 106
BclA-CTD-Pro159Ser 3.5 3 106
BclA-CTD-Ser129Ala-Pro159Ser 4.2 3 106
BclA-CTD-Glu130Gln-Pro159Ser 3.2 3 106
BclA-CTD-Bc 3.5 3 106
BclA-CTD-Bt 3.4 3 106
VLR4 has similar binding affinities for BclA despite amino acid changes
corresponding to differences in the sequences of BclA of Ba, Bc, and
Bt. The BclA mutation created to disrupt crystal packing, Thr185Asn,
shows a slight increase in affinity for VLR4. See also Figure S3.
Structure
VLR4 Recognition of BclABclA-CTD-Thr185Asn mutant surprisingly showed a 4-fold
increase in affinity, with a Kd of 0.6 mM, indicating that the muta-
tion did not disrupt the epitope for VLR4 and may have even
slightly enhanced the VLR4-BclA interaction.
Structure of VLR4-BclA
The asymmetric unit (asu) of the crystal contains three VLR4
head domain monomers (chains D, E, and F) bound to the
trimeric BclA (chains A, B, and C) such that each VLR4 contacts
a single BclA monomer using its concave surface (Figure 1).
VLR4 binds lower-down BclA than perhaps expected near the
proximal end of BclA with respect to the surface of the spore,
and the C terminus of the VLR4 head domain points away from
the spore where it would normally connect to the decameric
VLR4. Although three VLR4 head domains are bound multiva-
lently to the BclA trimer using identical binding surfaces, one of
the VLR4 domains shows a significant amount of disorder, as
reflected by increased B values and substantially fewer contacts
in the crystal lattice. Nevertheless, the concave surface of this
less-ordered VLR4 (chain F) in contact with BclA has lower B
values and better electron density than its more distal region.
VLR4 uses its six-stranded b sheet of the concave surface, as
well as LRRCT, to bury 480 A˚2 of surface area on BclA. The VLR4
concave surface lies along the proximal end of each BclA mono-
mer and primarily contacts the loop regions connecting strands
of the two b sheets. The extended antigen-contacting loop of
LRRCT lies across a shallow groove between two of these loops.
Six hydrogen bonds are formed between VLR4 and BclA, four of
which are contributed by the LRRCT (Figure 2). Because the
LRRCT-loop contributes a greater fraction of the surface buried
on VLR4 than any single LRR motif and provides the most
hydrogen bonds, this loop is likely responsible for most of the
antigen-binding specificity of VLR4.
VLR4 Mutagenesis and Binding to BclA
In a previous study (Herrin et al., 2008), several VLRBswith highly
similar sequences were isolated as binders of BclA-CTD,
including VLR4 (see Figure S1 available online), and contain
highly identical LRRCT-loops, bind to BclA with similar affinities
as VLR4, and display significant species specificity for theStructure 20,spores of B. anthracis. Although several VLR mutagenesis
experiments were described, with the VLR4-BclA structure
now in hand, we can now ask more specific questions about
the contributions of particular residue positions to differences
in antigen recognition among these VLRBs. For instance, posi-
tion 55 of VLR4 is a His, whereas an Arg in highly related VLRBs
is important for BclA binding. However, His55 does not contact
BclA in the VLR4-BclA complex structure, and mutation to Arg
in VLR4 did not significantly alter binding to BclA (Table 3). We
also probed position 106 at the edge of the VLR4-BclA interface
that is Ile in VLR4, but Thr, Asn, Asp, or Ile in other BclA-binding
VLRBs. Mutation of Ile106 to Thr reduced binding of VLR4 for
BclA by approximately 8-fold (Table 3).
BclA Mutagenesis and VLR4 Specificity
VLR4 shows remarkable specificity for B. anthracis Sterne
(Ba) spores but does not bind B. cereus T (Bc) or Bacillus
thuringiensisKurstaki (Bt) spores (Herrin et al., 2008). This finding
is in contrast to many conventional vertebrate antibodies against
BclA, which show some amount of cross-reactivity among
Bacillus species (Liu et al., 2008; Nuttall et al., 2011). To better
understand this discrimination, we compared sequence differ-
ences of the nonbinding bacterial specieswith BclA fromBa (Fig-
ure S2) and mapped them onto the BclA structure. Very few
differences are found in or near the VLR4-binding site (Figure 3),479–486, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 481
Figure 2. Molecular Interactions of VLR4 with BclA
Detailed view of molecular interactions between VLR4 and BclA-CTD.
(A) The concave surface of VLR4 (green and blue) contributes two hydrogen bonds (red dashes) and buries hydrophobic surface on BclA (yellow).
(B) The LRRCT (pink) makes interactions with BclA (yellow) using both the LRRCT-loop and Asn164, which lies between the loop and structurally conserved
Cys167. The LRRCTmakes four hydrogen bonds to BclA and buriesmore surface area than any other single LRRmotif from the concave surface. BclA contacting
residues are shown as sticks with the remainder of BclA represented as surface.
See also Figure S1.
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VLR4 Recognition of BclAand only one difference in a contact residue arises in Bc
at Ser129Ala, with a nearby sequence difference in Bt at
Glu130Gln. The two nonbinding species also share a different
residue at nearby Pro159Ser, and we hypothesized that muta-
tion of this Pro to Ser might alter the conformation of a loop
that is contacted by VLR4 and, hence, alter binding to the
VLR4 LRRCT-loop. We, therefore, determined the crystal struc-
ture of the BclA-CTD-Pro159Ser mutant (Table 1) and were
surprised to find that mutation at this position had no effect on
the loop conformation. We also tested binding of monomeric
VLR4 to Ser129Ala, Glu130Gln, and Pro159Ser BclA-CTD single
and double mutants, as well as binding to recombinant BclA-
CTD from Bc and Bt (Table 2). Again, to our surprise, no signifi-
cant differences were found in binding affinity among any of
these mutants compared to Ba wild-type BclA-CTD. In addition,
with multimeric VLR4, we observed strong binding to recombi-
nant BclA-CTD from each species. However, we were able to
confirm the previous observation that VLR4 is specific for Ba
spores, as distinct from recombinant Ba BclA, and little, if any,
binding to Bc spores (Figure S3) (Herrin et al., 2008). We also
tested VLR4 binding to modified Ba spores with a shortened
central collagen-like region of 51 residues (strain CLT314) thatTable 3. Binding ofMonomeric VLR4 Variants to RecombinantBa
BclA-CTD
Sample Kd (M)
VLR4 3.0 3 106
VLR4-His55Arg 2.7 3 106
VLR4-Ile106Thr 24.0 3 106
The VLR4 His55Arg mutation has no significant impact on BclA binding,
but Ile106Thr shows greatly reduced affinity, suggesting that other BclA-
binding VLRBs recognize the BclA epitope differently.
482 Structure 20, 479–486, March 7, 2012 ª2012 Elsevier Ltd All righis much shorter than Ba BclA (228 residues), Bc BclA (123 resi-
dues), or Bt BclA (117 residues). VLR4 binds this modified BclA
onBa spores nearly as well as wild-type (Figure S3). We interpret
these results to mean that VLR4 recognizes and discriminates
amongBclAs only in the context of bacterial spores, independent
of the length of the collagen-like region, and not with regard to
the respective recombinant proteins, when expressed in E. coli.
On the spore, BclA is heavily O-glycosylated on its central
collagen-like region (Daubenspeck et al., 2004), and it is possible
that additional glycosylation occurs on the CTD in Bc and Bt
BclA, although we do not observe this in Ba BclA (C.L.T., unpub-
lished data). VLR4 binds across a short stretch of threonineFigure 3. Species Specificity of VLR4
Comparison of VLR4 bound to BclA (A) withBacillus sequence polymorphisms
mapped onto the BclA structure (B) shows that VLR4 recognizes a surface on
BclA that is largely devoid of sequence differences seen in the different
Bacillus strains. Differences from Ba that are found in Bc are colored and
labeled in red, Bt in blue, and those that differ from Ba in both strains in purple.
See also Figure S2.
ts reserved
Figure 4. Glycosylation of B. cereus Spores Blocks VLR4 Binding
Bacillus spores were treated with periodate to remove the majority of the
glycans from the surface of the spores. VLR4 is unable to bind the nontreated
Bc spores. However, after treatment with periodate, VLR4 recognizes Bc
spores to a much greater extent than unmodified spores, suggesting that
glycosylation of theBc spores prevents VLR4 binding. Periodate treatment has
no effect on the strong binding of VLR4 to Ba spores.
Figure 5. Comparison of VLRB-Binding Interfaces with Different
Antigens
The concave surface of each VLRB is represented as a surface highlighting the
proximity of each amino acid to its respective antigen in angstroms. The
surface used by VLRB to contact antigens favors the use of the C-terminal LRR
motifs, and VLR4 is heavily biased toward the use of the C-terminal ends of the
b strands of these motifs. The LRRCT motif (pink) of each VLRB shows
dramatically different lengths and conformations in their LRRCT-loops.
Structure
VLR4 Recognition of BclAresidues (amino acids 183–185, Figure S2) and would be pre-
vented from binding if these residues were sites of O-linked
glycosylation. To test this hypothesis, we treated Ba and Bc
spores with sodium meta-periodate, which partially removed
the glycans from the spore surface. Deglycosylation of Bc
spores significantly enhances the VLR4 binding to this strain,
supporting our hypothesis that the VLR4 epitope on BclA is
a site of O-glycosylation on Bc spores (Figure 4). Binding of
VLR4 to deglycosylated Ba spores was unaltered compared to
nontreated spores, indicating that treatment did not disrupt or
enhance VLR4 interactions with the BclA epitope. Although we
expect this treatment removed the majority of glycans, a partial
adduct likely remains attached to the protein that would reduce
binding to the treated Bc spores compared to the Ba spores.
DISCUSSION
To our knowledge, the crystal structure of VLR4-BclA complex
marks only the third VLRB-antigen complex to be determined
thus far, but common themes for VLR-antigen recognition are
now beginning to emerge. VLRs use their concave surface
created by the LRR motifs to interact with antigens, as distinct
from TLRs, which can use this concave surface but also other
surface regions and faces for primary interactions with antigen.
Although the number of LRRs that contact antigen in VLRs is
variable, antigen does not contact the entire concave surface
in much the same way that antibodies do not usually use
their entire combining site surface for contacting antigen. The
LRRCT-loop is key to the binding of antigens by VLRB, similar
to the focused role of the variable heavy chain and the comple-
mentarity-determining region H3 in conventional vertebrate anti-
bodies, especially for smaller antigens. VLR binding of antigen
seems to be consistently focused on the C-terminal LRRs (Fig-
ure 5) proximal to the extended loop of LRRCT. This bias is
most evident in the minimal use of the LRRNT. Although this
motif contains variable residues at potential antigen-contactingStructure 20,positions, to our knowledge, VLR4 is the only VLRB so far that
has been demonstrated to bind to antigen using LRRNT but,
even so, only makes minimal contacts to BclA. Although this
may change as more examples become available, the evidence
so far suggests that VLRs bind antigens primarily using their
C-terminal repeats, with the N-terminal repeats being used
less frequently, perhaps reflecting the importance of LRRCT in
binding and specificity.
It was noted in both the VLRB.2D-hen-egg lysozyme (HEL)
and VLR.RBC36-H-trisaccharide complex structures that the
LRRCT-loop contains an aromatic residue that makes479–486, March 7, 2012 ª2012 Elsevier Ltd All rights reserved 483
Figure 6. BclA-Binding VLRBs Likely Recognize Subtly Different
Epitopes
VLRBs with high amino acid sequence homology to VLR4 likely bind a similar
epitope on BclA. Nevertheless, an Arg at position 55 of other VLRBs was
determined to be important for binding, and position 106 can be Ile, Asn, Asp,
or Thr, suggesting that these VLRBs recognize BclA slightly differently than
VLR4. The proposed rotation of VLR4 on BclA is indicated as a hypothesized
recognition mode for these VLRBs.
Structure
VLR4 Recognition of BclAimportant contacts with antigen. For VLR.RBC36, a Trp residue
sandwiches the H-trisaccharide against the concave surface of
the VLR (Han et al., 2008) and shields the LRRCT-loop from
further interaction with the ligand. For VLRB.2D, the LRRCT-
loop is inserted into the active site of HEL, burying Leu and
Asn residues and positioning a Tyr near other aromatic residues
in the active site (Velikovsky et al., 2009). In contrast, VLR4 lacks
an aromatic residue in the LRRCT-loop. However, similar to
VLRB.2D, VLR4 uses both side-chain and main-chain atoms of
LRRCT for hydrogen bonding with ligand. VLR4 also makes
use of the region between the LRRCT-loop and the structurally
conserved Cys167, which is located on the C-terminal side of
the loop, where Asn164 hydrogen bonds to BclA (Figures 2
and S1). Whereas VLRB.2D inserts its LRRCT-loop directly into
a deep pocket, the LRRCT-loop of VLR4 meanders across
a shallow groove on BclA such that Gly158 at the loop apex
does not contact BclA. This latter mode of interaction is reminis-
cent of VLRA.R2.1, which uses the LRRCT-loop to bind a flat
surface on the antigen rather than in a pocket (Deng et al., 2010).
VLR4 mutagenesis experiments lead us to hypothesize that,
although the set of BclA-binding VLRBs (Herrin et al., 2008) is
highly similar in sequence, they likely recognize BclA with subtle
differences. The exceptional degree of similarity, particularly in
the highly variable LRRCT-loop, would suggest that they all
recognize a similar epitope on BclA. However, the binding differ-
ences observed by our mutagenesis seem to indicate that the
other identified VLRB clones could rotate on BclA (Figure 6).
The proposed rotation would bring the more N-terminal variable484 Structure 20, 479–486, March 7, 2012 ª2012 Elsevier Ltd All righpositions on the concave surface b strands into greater contact
with antigen, whereas the C-terminal positions would have
a diminished role in antigen binding. Such structural variation
in antigen recognition among these VLRBs would account for
the observed variation among the isolated VLRB at position
106 and allow an Arg55 to contact Glu130 on BclA accounting
for the previously ascribed importance of this position. In fact,
comparison of the available VLRB-antigen complex structures
demonstrates that VLR4 is much more shifted toward the use
of the C-terminal ends of the b strands for antigen recognition
than seen previously (Han et al., 2008; Velikovsky et al., 2009).
The proposed rotation of sequence-related BclA-binding VLRBs
on the surface of BclA would allow contact with VLRB positions
that interact with antigen in the other structures (Figure 5).
Although VLR4 shows remarkable specificity for the spores of
Ba over Bc and Bt, the epitope on BclA is relatively conserved
across these strains. Whereas some neighboring sequence
differences exist on the surface of BclA, mutation of these resi-
dues singly or in combination does not abrogate binding to
VLR4 (Table 3). Thus, we conclude that VLR4 discrimination of
Bacillus species only occurs in the context of the bacterial spore.
Glycosylation ofBc spores blocks recognition by VLR4 and likely
is the mode of species discrimination by VLR4. VLR4 binding to
deglycosylated Bc spores was less than to Ba spores, which we
attribute to partial residual sugar adducts on BclA. However, an
additional possibility is the differential packing of proteins in the
exosporium limiting the accessibility to the VLR4 epitope on the
underside of BclA in these species (Sylvestre et al., 2003; Ball
et al., 2008). Indeed, it is possible that the VLR4 epitope is not
accessible to the Fab regions of conventional Ig antibodies,
e.g., owing to their much larger size (Nuttall et al., 2011). These
data on fine discrimination of BclA on spores, therefore, suggest
that VLR4 would make an excellent diagnostic tool for the iden-
tification B. anthracis spores and encourage testing of VLR4
against a greater panel of B. cereus group strains. No natural
polymorphisms in BclA-CTD are found in B. anthracis species
but are found among strains of B. cereus and B. thuringiensis
species. Sequences identical to the Ba, Bc, or Bt BclA-CTD
amino acid sequences can be found in both B. cereus and B.
thuringiensis species. Because VLR4 discriminates on the basis
of glycosylation of a conserved protein epitope, use of VLR4 to
recognize B. anthracis spores overcomes the issue of recogni-
tion of BclA having amino acid sequences identical to the other
Bacillus species. Use of VLR4 as a diagnostic tool able to identify
B. anthracis spores despite naturally occurring amino acid
polymorphisms would be invaluable for the identification of bio-
terrorism agents with obvious biodefense applications.
The structure presented here shows that VLR4 interacts with
BclA using its concave surface and LRRCT-loop similar to
other VLRB-antigen complexes. This structure combined with
the mutagenesis and binding studies of VLR4 reveals that
sequence-related VLRBs likely recognize the BclA epitope with
slight differences. It is interesting to speculate that BclA binding
by sequence-related VLRBs (Herrin et al., 2008) may share
a common precursor that then diversified to bind the BclA
epitope in subtly different ways or may, instead, have arisen
by parallel evolution. However, this determination will have to
wait for a clearer understanding of VLRB assembly, diversifica-
tion, and selection. Importantly, our studies of VLR4 speciests reserved
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VLR4 Recognition of BclAspecificity have revealed that VLR4 can be used as an excellent
diagnostic tool for the identification of B. anthracis spores.
EXPERIMENTAL PROCEDURES
Monomeric VLR4 Expression and Purification
Amino acids 22–167 of VLR4 were cloned into pBAC6 using the SacII and
BamHI restriction sites putting the gene in frame with an N-terminal gp64
signal peptide and 6-His tag. This construct lacks the C-terminal 82 amino
acids containing the Thr/Pro stalk, putative GPI linkage site, and Cys-rich
region used for multimerization. The VLR4-pBAC6 transfer vector was
cotransfected with ProFold-ER1 (AB Vector) into Sf9 cells using Cellfectin
(Invitrogen). Recombinant baculovirus was amplified to a titer of approxi-
mately 109 pfu/ml. This virus was used to infect Sf9 cells at a density of
2.0 3 106 cells/ml at a multiplicity of infection of six. Cultures were harvested
after 2 days of shaking at 28C. Culture supernatants were buffer exchanged
into 10 mM Tris-Cl (pH 8.0), 300 mM sodium chloride, 20 mM imidazole, and
passed over Ni-NTA (QIAGEN). The resin was washed with 10 mM HEPES
(pH 6.9), 300 mM NaCl, 30 mM imidazole, and protein was eluted in the
same buffer with 300 mM imidazole. Protein fractions were concentrated
and run on a Superdex 75 size exclusion column in 50 mM HEPES (pH 6.9),
100 mM NaCl. The protein eluted at the predicted molecular weight of the
monomeric species. The protein was finally purified by cation exchange on
a MonoS column in 50 mM Bis-Tris-Cl (pH 6.5) and eluted with a gradient of
0–0.5 M NaCl. Purified protein was buffer exchanged into 50 mM HEPES
(pH 6.8) and concentrated to an A280 of 8.1.
BclA Mutagenesis, Expression, and Purification
The recombinant B. anthracis BclA protein was from the Sterne strain, which
has 400 amino acids (Boydston et al., 2005). The C-terminal 138 amino acids
(residues 263–400, which include the CTD) were cloned into pET28b with an
N-terminal His6 tag and TEV cleavage site. The numbering of the amino acids
in BclA varies among strains due to length polymorphism of the collagen-like
region. The numbering of BclA presented here corresponds to B. anthracis
strain Ceb 9732 for ease of comparison with previously determined structures
of the BclA-CTD (residues 77–214). Mutagenesis of this construct to disrupt
a common crystal packing interaction of apo BclA-CTD (Boydston et al.,
2005; Liu et al., 2008) was accomplished by MPIPE (Klock et al., 2008) and
resulted in Thr185 to Asn mutation. This construct also contains a C-terminal
cloning artifact encoding the sequence FRFRN. Vectors containing the BclA-
CTD coding sequences were transformed into E. coli BL21(DE3) (Novagen).
Cultures were induced with IPTG at an OD600 of 0.8, and expression was
carried out overnight at 16C. Cells were lysed using a continuous flow cell
disruptor in 50 mM sodium phosphate (pH 7.5), 500 mM NaCl, 30 mM imid-
azole. Cleared lysates were bound to Ni-NTA and washed in the same buffer.
The protein was eluted in 50 mM sodium phosphate, 500 mM NaCl, 300 mM
imidazole, concentrated, and run on a Superdex 200 size exclusion column
in 50 mM Tris-Cl (pH 8.0), 150 mM NaCl, where the protein eluted as a trimeric
species. These protein fractionswere concentrated to an A280 of 9.0. The BclA-
CTD-wt protein was treated similarly; however, the expressed protein was
recalcitrant toward being further concentrated.
VLR4-BclA Crystallization
VLR4-BclA-CTD-Thr185Asn crystals grew in 15%PEG 6000, 1.2M LiCl, 0.1 M
sodium citrate (pH 5.26), as clusters of thin plates after 3–7 days and were
cryoprotected in 25% glycerol for storage and data collection. Diffraction
data were collected at APS beamline 23ID-D. We initially located three BclA
monomers and a single VLR4 by molecular replacement (MR) using PDB
2R6Q for BclA and PDB 2R9U for a VLRB as MR models, and placed an addi-
tional two VLR4molecules by hand into residual electron density after the initial
MR solution.
Crystals of BclA-CTD-Pro159Ser grew in 0.7 M ammonium phosphate
monobasic, 0.1 M sodium citrate (pH 5.0) at room temperature in a hexagonal
plate morphology and were cryoprotected in a 1:1 mixture of 5 M sodium
malonate (pH 6.4) and mother liquor. Diffraction data were collected at ALS
beamline 8.2.1 and indexed and processed with HKL2000 (Otwinoski and
Minor, 1997). Phasing was done by MR with Phaser (McCoy et al., 2007) usingStructure 20,PDB 2R6Q as aMRmodel for BclA.We located a single BclA-CTDmonomer in
the asu with identical crystal packing to PDB 2R6Q.
Rigid body and restrained refinements were performed in Refmac (Murshu-
dov et al., 1997) and Buster-TNT (Blanc et al., 2004) with the final refinements
performed in Refmac. A summary of the data processing and refinement
can be found in Table 1. The VLR4-BclA structure was analyzed using
HBPLUS (McDonald and Thornton, 1994), MS (Connolly, 1993), Contacsym
(Sheriff et al., 1987), and MolProbity (Davis et al., 2007) to assess hydrogen
bonding, buried surface areas, van der Waals contacts, and structure quality,
respectively.
Binding of VLR4 and BclA-CTD
Binding of VLR4 to mutant BclA-CTD was determined using biolayer
interferometry on an OctetRED (ForteBio). DNA encoding the peptide
MSGLNDIFEAQKIEWHE was inserted N terminal of the BclA-CTD coding
sequence for biotin ligation. Protein constructs were expressed as above
and prepared in 100 mM Tris-Cl (pH 8.1) to which 103 reaction buffer was
added (final concentrations 10 mM ATP disodium salt, 10 mM magnesium
acetate, and 50 mM D-biotin) and 100 mg of BirA, biotin ligase. The reaction
was incubated overnight at 37C and then buffer exchanged on a Superdex
200 16/60 column. The BclA proteins were not concentrated. Biotinylated
protein was loaded onto streptavidin biosensors and incubated with a dilution
series of monomeric VLR4 produced as described above. Curve fitting was
done using the OctetRED analysis software.
For surface plasmon resonance experiments, wild-type BclA-CTD proteins
were prepared as above without the biotinylation peptide or reaction with BirA.
VLR4 mutants were generated by MPIPE and expressed and purified as the
monomeric wild-type protein. VLR4 affinity was analyzed using a Biacore
3000 (GE) instrument. Recombinant BclA was coupled to a Biacore CM5
chip using amine chemistry. A reference channel was created by capping off
one channel of the EDC/NHS-activated CM5 chip with ethanolamine.
Recombinant monomeric VLR4 was injected over the biosensor surface in
duplicate at a flow rate of 30 ml/min in 10 mM MES, 150 mM NaCl, 0.05%
Tween 20, 3 mM EDTA (pH 6.5). MES buffer without VLR4 was injected during
the course of the experiment for double referencing. The surface was regener-
ated after each cycle with a 30 s pulse of 50 mM NaOH. Sensorgrams were
processed using BiaEvaluation (GE) and Scrubber2 software (BioLogic soft-
ware, Australia). Sensorgrams were zeroed on the y axis, and bulk refractive
index changes were removed by subtracting the reference channel.
Periodate Treatment of Bacillus Spores
B. anthracis and B. cereus spores (1 3 106) were washed twice with 0.1 M
sodium acetate buffer (pH 5.5), then incubated with 20 mM sodiummeta-peri-
odate (Thermo Scientific) in acetate buffer at room temperature for 1–6 hr. After
incubation, the spores were washed three times with 0.1M Tris buffer (pH 8.0),
before staining with purified, multivalent VLR4 or a nonspecific control VLRB
(C4.39) in FACS buffer. The spore samples were acquired using an Accuri
C6 flow cytometer and analyzed with CFLOW software.
ACCESSION NUMBERS
Coordinates for VLR4-BclA-CTD-Thr185Asn and BclA-CTD-Pro159Ser struc-
tures have been deposited in the PDB with accession codes 3TWI and 3TYJ,
respectively.
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